Hand, foot, and mouth disease (HFMD) is a common viral illness usually affecting infants and children but can affect adults. The infection usually involves the hands, feet, mouth, and sometimes, even the genitals and buttocks. The cause of hand, foot and mouth disease is coxsackievirus A type 16 in most cases, but the infection can also be caused by many other strains of coxsackievirus. In the western Pacific, hand, foot, and mouth disease has been linked to enterovirus. The coxsackievirus is a member of the Picornaviridae family which includes non-enveloped single-stranded RNA viruses.
Hand, foot, and mouth disease is a viral exanthem, and it is most commonly caused by the coxsackievirus, of the Enterovirus family. Coxsackievirus A16 and enterovirus A71 are the serotypes that are most commonly implicated as the causative agents.
This viral infection is not indigenous to one area in particular but occurs worldwide. As children (particularly those younger than seven years of age) tend to be infected at a higher rate than adults you can see outbreaks in daycares, summer camps or within the family. These outbreaks are usually during the summer and early autumn.
Hand, foot, and mouth disease occurs at an equal frequency in both genders, but older epidemiological data seem to suggest that the frequency of infection is slightly higher in males.
The majority of people infected with coxsackievirus are children under the age of 10. Because the virus is shed in the stools for many weeks, some studies indicate that family members and close contacts are also at risk for developing hand, foot and mouth disease.
The spread of the human enterovirus is mediated by oral ingestion of the shed virus from the gastrointestinal or upper respiratory tract of infected hosts, or via vesicle fluid or oral secretions. After ingestion, the virus replicates in the lymphoid tissue of the lower intestine and the pharynx and spreads to the regional lymph nodes. This can be spread to multiple organs including the central nervous system, heart, liver, and skin.
Hand, foot and mouth disease can start with a low-grade fever, reduced appetite, and general malaise. The most common hand, foot, and mouth disease presenting symptom is usually mouth or throat pain secondary to the enanthem. The presence of vesicles surrounded by a thin halo of erythema, eventually rupturing and forming superficial ulcers with a grey-yellow base and erythematous rim. The exanthem can be macular, papular or vesicular. The lesions are non-pruritic, and typically not painful. The exanthem involves the dorsum of the hand, feet, buttocks, legs, and arms.
Hand, foot and mouth disease can also present with atypical features like concomitant aseptic meningitis. Enterovirus infections that cause hand, foot, and mouth disease are notorious for involving the central nervous system (CNS) and may cause encephalitis, polio-like syndrome, acute transverse myelitis, Guillain-Barre syndrome, benign intracranial hypertension and acute cerebellar ataxia.
The diagnosis of hand, foot, and mouth disease is usually made clinically. The virus can be detected in the stool for about 6 weeks after infection, however, shedding from oropharynx is usually less than 4 weeks. Light microscopy of biopsies or scrapings of vesicles will differentiate hand, foot, and mouth disease from varicella zoster virus and herpes simplex virus.
While serology is not sensitive to make a diagnosis of hand, foot, and mouth disease, levels of IgG can be used to monitor recovery. In some centers, serology is used to differentiate enterovirus 71 from coxsackievirus as this has prognostic significance. Today, polymerase chain reaction assays are available in most centers to confirm the diagnosis of coxsackievirus.
Hand, foot, and mouth disease is a mild clinical syndrome and will resolve within 7 to 10 days. Treatment is primarily supportive. Pain and fever can be managed with NSAIDs and acetaminophen. Making sure the patient remains well hydrated is important. Additionally, a mixture of liquid ibuprofen and liquid diphenhydramine can be used to gargle with which helps coat the ulcers, ameliorating the pain.
Ribavirin, quinacrine, and amantadine have all been used off-label to treat severe cases of enterovirus 71 induced hand, foot, and mouth disease disease.
Over the past decade, researchers have developed specific treatments to manage enterovirus 71 induced hand, foot, and mouth disease because of its severe neurological complications. So far, no drug has been approved, but promising novel agents include molecular decoys, translation inhibitors, receptor antagonists and replication inhibitors. One new antiviral agent that has shown promise in the treatment of enterovirus 71 is pleconaril.
The prognosis for the majority of patients with hand, foot, and mouth disease is excellent. Most patients recover within a few weeks without any residual sequelae. The acute illness usually lasts 10 to 14 days, and the infection rarely recurs or persists. However, some patients with hand, foot, and mouth disease may develop serious complications which include the following:
The majority of patients with coxsackievirus-induced hand, foot, and mouth disease are treated as outpatients, but those who have CNS involvement may require admission for close monitoring. These patients often require imaging studies of the brain to guide treatment and recovery. Infants may develop dehydration, especially if they develop painful oral ulcers and may require Intravenous hydration. Admission is highly recommended in any infant with hand, foot, and mouth disease who shows signs of severe disease and lethargy. The virus is shed in the stools for a few weeks; hence, patients should be educated about hand washing and maintenance of good personal hygiene.
|[A child with a fever and rash]., Herwegen B,Frank R,, Nederlands tijdschrift voor geneeskunde, 2017 [PubMed PMID: 28247832]|
|Onychomadesis after hand-foot-and-mouth disease., Gan XL,Zhang TD,, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2017 Feb 21 [PubMed PMID: 28246241]|
|Tracking and predicting hand, foot, and mouth disease (HFMD) epidemics in China by Baidu queries., Xiao QY,Liu HJ,Feldman MW,, Epidemiology and infection, 2017 Feb 22 [PubMed PMID: 28222831]|
|Shedding light on onychomadesis., Salgado F,Handler MZ,Schwartz RA,, Cutis, 2017 Jan [PubMed PMID: 28207011]|
|Common Skin Conditions in Children: Skin Infections., Rayala BZ,Morrell DS,, FP essentials, 2017 Feb [PubMed PMID: 28196318]|
|The impact of hand, foot and mouth disease control policies in Singapore: A qualitative analysis of public perceptions., Siegel K,Cook AR,La H,, Journal of public health policy, 2017 Feb 8 [PubMed PMID: 28179628]|
|Antiviral Activity of Acid beta-Glucosidase 1 on Enterovirus 71, a Causative Agent of Hand-Foot-Mouth Disease., Nakata K,Takeda S,Tanaka A,Kwang J,Komano J,, The Journal of general virology, 2017 Jan 27 [PubMed PMID: 28141506]|
|[Application of esmolol in severe hand, foot, and mouth disease]., Zhu L,Qi BX,Fang DH,Qi GJ,Gao K,Hu BL,, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2017 Jan [PubMed PMID: 28100321]|
|A Case-control Study on Risk Factors for Severe Hand, Foot and Mouth Disease., Zhang D,Li R,Zhang W,Li G,Ma Z,Chen X,Du Z,Li Z,Guo P,Lin Z,Lu J,Hao Y,, Scientific reports, 2017 Jan 13 [PubMed PMID: 28084311]|
|Proximal onycholysis as a complication of hand, foot, and mouth disease., Bağcı IS,Flaig MJ,Ruzicka T,Sárdy M,, International journal of dermatology, 2017 Mar [PubMed PMID: 28083877]|
|The exposure-response relationship between temperature and childhood hand, foot and mouth disease: A multicity study from mainland China., Xiao X,Gasparrini A,Huang J,Liao Q,Liu F,Yin F,Yu H,Li X,, Environment international, 2017 Mar [PubMed PMID: 28069250]|